ALSA Ventures Launches Promatix to Develop Next Generation Novel Oncology Therapeutics
Search jobs ALSA Ventures Launches Promatix to Develop Next Generation Novel Oncology Therapeutics LONDON--(BUSINESS WIRE)--ALSA Ventures today announced the launch of Promatix Inc., a Delaware incorporated company, to develop novel therapeutics with the potential to transform the treatment of cancer. Promatix will use its multi-omic proprietary database, TxPro, to mine for novel, and validate existing, drug targets. “As we mark off the 20 th anniversary of drafting the human genome, it’s clear we’re still in the early innings of a revolution in molecular biolog...
Source: pharmiweb.com